Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -453,816 | -1,131,301 | -766,409 | -461,203 | -213,416 |
| Depreciation Amortization | 1,312 | -11,273 | -11,421 | -10,042 | -6,101 |
| Accounts payable and accrued liabilities | 16,857 | 9,535 | 20,036 | 491 | -8,270 |
| Other Working Capital | -16,945 | 86,823 | 54,577 | -1,866 | 2,437 |
| Other Operating Activity | 98,427 | 148,475 | 79,714 | 56,428 | 30,915 |
| Operating Cash Flow | $-354,165 | $-897,741 | $-623,503 | $-416,192 | $-194,435 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 174,153 | 134,048 | 57,241 | 29,043 | -12,683 |
| PPE Investments | -1,538 | -15,990 | -14,065 | -10,716 | -3,266 |
| Investing Cash Flow | $172,615 | $118,058 | $43,176 | $18,327 | $-15,949 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 244,215 | 244,215 | 250,000 | N/A |
| Common Stock Issued | 238,996 | 377,089 | 11,621 | 7,473 | 892 |
| Other Financing Activity | -252 | 220 | 29 | -16 | -18 |
| Financing Cash Flow | $238,744 | $621,524 | $255,865 | $257,457 | $874 |
| Beginning Cash Position | 388,603 | 546,762 | 546,762 | 546,762 | 546,762 |
| End Cash Position | 445,797 | 388,603 | 222,300 | 406,354 | 337,252 |
| Net Cash Flow | $57,194 | $-158,159 | $-324,462 | $-140,408 | $-209,510 |
| Free Cash Flow | |||||
| Operating Cash Flow | -354,165 | -897,741 | -623,503 | -416,192 | -194,435 |
| Capital Expenditure | -1,538 | -15,990 | -14,065 | -10,716 | -3,266 |
| Free Cash Flow | -355,703 | -913,731 | -637,568 | -426,908 | -197,701 |